Table 2.
Invasive disease-free survival | Overall survival | Percentage with both breasts during lifetime | |||
---|---|---|---|---|---|
Baseline Δ | 11.7 months | 2.1 months | -8.6% | ||
Variable | Baseline | Range Studied | Δ of Range (months) | Δ of Range (months) | Δ of Range (%) |
Local recurrence at 10-years | 0.2495 | 0.15 - 0.35 | 7.0 - 16.7 | 1.3 – 3.0 | -7.6 to -9.6 |
Reduction in local recurrence with RT | 0.46 | 0.30 - 0.70 | 8.0 – 17.4 | 1.4 – 3.1 | -11.6 to -4.1 |
Proportion of invasive LR | 0.50 | 0.30 - 0.70 | 9.0 - 15.9 | 1.4 - 2.9 | -9.0 to -8.2 |
Proportion of invasive new cancer | 0.69 | 0.30 - 0.80 | 11.2 - 11.9 | 2.1 - 2.2 | -9.0 to -8.5 |
Contralateral-breast cancer/yr | 0.008 | 0.004 - 0.010 | 12.1 – 11.6 | 2.1 – 2.2 | -10.0 to -8.1 |
Proportion mastectomy at recurrence or new cancer if no prior RT | 0.32* | 0.20 – 0.48 | 11.7-11.5 | 2.1 – 2.1 | -11.7 to -4.3 |
RT = radiation therapy
LR = local recurrence
Δ = difference with the addition of radiation therapy
= in baseline analysis, this variable is a function of the stage of recurrence or new diagnosis; on average it is 0.32